STALEY CAPITAL ADVISERS’s MoonLake Immunotherapeutics MLTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-580,000
| Closed | -$6.35M | – | 177 |
|
|
2022
Q1 | $6.35M | Hold |
580,000
| – | – | 0.32% | 51 |
|
|
2021
Q4 | $5.74M | Hold |
580,000
| – | – | 0.27% | 57 |
|
|
2021
Q3 | $5.71M | Buy |
580,000
+80,000
| +16% | +$788K | 0.31% | 53 |
|
|
2021
Q2 | $5.18M | Buy |
500,000
+200,000
| +67% | +$2.07M | 0.27% | 56 |
|
|
2021
Q1 | $3.06M | Buy |
300,000
+253,879
| +550% | +$2.59M | 0.17% | 68 |
|
|
2020
Q4 | $524K | Buy |
+46,121
| New | +$524K | 0.03% | 118 |
|